Rooted Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.41M Buy
2,013
+503
+33% +$514K 0.59% 37
2026
Q1
$1.39M Buy
1,510
+1,109
+277% +$1.12M 0.37% 50
2025
Q4
$444K Sell
401
-2
-0.5% -$1.91K 0.12% 87
2025
Q3
$339K Sell
403
-165
-29% -$123K 0.1% 88
2025
Q2
$451K Buy
568
+36
+7% +$28K 0.16% 73
2025
Q1
$393K Sell
532
-57
-10% -$47.4K 0.17% 66
2024
Q4
$456K Sell
589
-32
-5% -$26.5K 0.18% 60
2024
Q3
$558K Buy
621
+106
+21% +$95.3K 0.25% 52
2024
Q2
$437K Buy
515
+12
+2% +$9.6K 0.19% 58
2024
Q1
$384K Buy
503
+24
+5% +$17.1K 0.19% 58
2023
Q4
$338K Buy
479
+18
+4% +$10.5K 0.18% 59
2023
Q3
$273K Sell
461
-12
-3% -$6.18K 0.17% 64
2023
Q2
$220K Buy
+473
New +$198K 0.15% 77

Other funds holding LLY

Rooted Wealth Advisors's LLY Position: Q2 2026 in Review

Rooted Wealth Advisors increased its Eli Lilly (LLY) stake by 33% in Q2 2026, buying an estimated $514K and bringing the position to 2,013 shares worth $2.41M. The position accounts for 0.59% of the portfolio, ranked #37.

Rooted Wealth Advisors first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Rooted Wealth Advisors held 2,013 shares of Eli Lilly worth $2.41M as of Q2 2026.
  • Rooted Wealth Advisors bought 503 Eli Lilly shares in Q2 2026, an estimated $514K.
  • Eli Lilly made up 0.59% of Rooted Wealth Advisors's portfolio in Q2 2026, its #37 holding.
  • Rooted Wealth Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Rooted Wealth Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.